Cargando…
EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy
Background and study aims The US FDA recently approved a cancer treatment with pembrolizumab based upon the tumor biomarker status of deficient mismatch repair (dMMR) rather than a specific disease-based approach. We sought to determine if endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) c...
Autores principales: | Gleeson, Ferga C., Levy, Michael J., Roden, Anja C., Boardman, Lisa A., Sinicrope, Frank A., McWilliams, Robert R., Zhang, Lizhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175678/ https://www.ncbi.nlm.nih.gov/pubmed/30302387 http://dx.doi.org/10.1055/a-0650-4447 |
Ejemplares similares
-
Effectiveness of EUS-Guided Fine-Needle Biopsy versus EUS-Guided Fine-Needle Aspiration: A Retrospective Analysis
por: Kuraoka, Naosuke, et al.
Publicado: (2021) -
The difference in histological yield between 19G EUS-FNA and EUS-fine-needle biopsy needles
por: Ang, Tiing Leong, et al.
Publicado: (2019) -
EUS-guided fine-needle core liver biopsy with a modified one-pass, one-actuation wet suction technique comparing two types of EUS core needles
por: Nieto, Jose, et al.
Publicado: (2020) -
EUS-guided fine-needle biopsy of gallbladder polypoid lesions
por: Kang, Sung Hoon, et al.
Publicado: (2020) -
Prospective evaluation of EUS-guided fine needle biopsy in pancreatic mass lesions
por: Larsen, M. H., et al.
Publicado: (2018)